Macroaxis: Personalized Investing
Simple Personalized Investing

RHO5 RHO RHO6 NOVB Recent Drops Macroaxis 20 Music and Video Money Funds 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for AMG

Amgen quote and profile

 
 Companies |  Insiders  | Dashboard  
     
81.7
  
STOCK
1.70  Macroaxis: 2.12 Up   2.12%  
Year To Date
52.9688.0
Last 1 Month(s)
78.7184.0
Trading Day 
81.781.7
May 24 2013 

Diversification Suggestion

Use Amgen to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals
Analyze Amgen Inc Trend or Check current 30 days Amgen correlation with market (S&P 500)
1 Month Beta -0.43  
Highest Price:  
Lowest Price:  
84.0  
78.71  
April 25 2013 
May 21 2013 
As returns on market increase, returns on owning Amgen are expected to decrease at a much smaller rate. During bear market, Amgen is likely to outperform the market.
Amgen Inc Almost negative betaAmgen Inc Beta Legend
AMG Germany XETRA #US0311621009DE
Amgen Inc
Healthcare
Biotechnology
Benchmark S&P 500
http://www.amgen.com
Contact Number: 805. 447. 1000
Currency: EUR - Euro
Traded on XETRA Stock Exchange
    
Current Valuation63.88 B
Shares Outstanding749.98 M
Revenue17.46 B
EBITDA7.05 B
 thisGreen AMG AMG.DE agains markets  2.12 % Macroaxis: change 2.12 Moved Up  
 
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 Germany DAX   0.56 % Macroaxis: 0.56 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Amgen Leadership

Robert Bradway Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee
Jonathan Peacock CFO and Executive VP

Amgen Price and Market Media

The median price of Amgen for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 81.65 with a coefficient of variation of 1.88. The daily time series for the period is distributed with a sample standard deviation of 1.53, arithmetic mean of 81.27, and mean deviation of 1.34. The Stock did not receive any noticable media coverage during the period.
Amgen         SP 500
Price Growth (%)
 

Amgen Summary

Amgen Inc [AMG] is traded on XETRA Stock Exchange in Germany. It is located in Thousand Oaks, CA and employs 18,000 people. The company currently falls under 'Large-Cap' category with current market capitalization of 61.61 B. Amgen Inc operates under Healthcare sector and is part of Biotechnology industry. This company has 749.98 M outstanding shares.
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic solutions in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
43 %
 
Follow Amgen with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Amgen to your reader
 

Amgen Research Report

Amgen vs. Roche

Correlation analysis and fundamentals comparison between Amgen Inc and Roche Holding AG

Amgen Executives

Jonathan Peacock CFO and Executive VP

Amgen Management

Madhavan Balachandran Executive VP of Operations
Sean MD Executive VP of RandD
Anthony Hooper Executive VP of Global Commercial Operations
David JD Sr. VP, General Counsel and Secretary
David Beier Sr. VP
Dr MD Consultant

Amgen Fundamentals

Debt to Equity vs Current Ratio
One Year High vs Cash Flow from Operations
Debt to Equity vs Revenue
Profit Margin vs Cash Flow from Operations

Amgen vs Competition

Amgen vs. Roche Holding AG
Amgen vs. Roche Holding AG
Amgen vs. Roche Holding AG
Amgen vs. Novo Nordisk A-S
Amgen vs. Novo Nordisk A-S
Amgen vs. Gilead Sciences Inc
Amgen vs. Biogen Idec Inc
Amgen vs. Alexion Pharmaceuticals Inc
Amgen vs. Actelion Ltd

Amgen May 24 2013 Opportunity Range

Downside Deviation2.07
Information Ratio(0.10)
Maximum Drawdown8.21
Value At Risk(2.62)
Potential Upside4.31

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium